News | Cardiac Diagnostics | September 12, 2017

Ultrasound Screening for Vascular Disease Saves One Life For Every 169 Patients Assessed

Results of the Danish VIVA Study reported at ESC 2017

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, according to late-breaking results from the VIVA trial presented at the 2017 European Society of Cardiology (ESC) Congress and and published in the Lancet. The combined screening for abdominal aortic aneurysm, peripheral artery disease, and hypertension gained more living years for lower costs than European cancer screening programs.

“National screening programs are implemented for different types of cancer, yet there is limited research on similar programs for asymptomatic cardiovascular disease – irrespective of the fact that it causes more deaths,” said principal investigator Prof. Jes Lindholt, professor of vascular surgery, Odense University Hospital, Denmark.

The Danish Viborg Vascular (VIVA) trial tested the mortality impact and cost-effectiveness of combined screening for abdominal aortic aneurysm, peripheral artery disease (PAD) and hypertension.

“These diseases are often asymptomatic and can be life threatening,” Lindholt said. “Of course, elective repair of an aneurysm can prevent dying of rupture. However, pharmacological therapy for peripheral artery disease, aneurysms or hypertension holds a much larger potential to reduce the risk of dying from coronary heart disease, stroke and heart attack.”

The prospective, randomized trial included all 50,156 men aged 65 to 74 years from the central region of Denmark. Half were invited to screening and the other half to usual care where disease is typically detected only if a man reacts to symptoms or is in contact with healthcare for other reasons. The primary outcome was all-cause mortality.

Men in the screening group underwent a 10 minute procedure in which their aorta was scanned using ultrasonography and their blood pressure was measured and compared for the ankle and the arm, as shown in the picture. Two specially trained nurses undertook the procedure.

More than 20 percent of those attending screening had positive test results: 3 percent had an abdominal aortic aneurysm, 11 percent had peripheral artery disease, and 11 percent had suspected hypertension that was untreated. “We were quite surprised that despite modern healthcare with diagnostic technology being available essentially everywhere, one out of five men had undiagnosed vascular disease,” Lindholt said.

Men who tested positive for abdominal aortic aneurysm and/or peripheral artery disease had a confirmatory test and consultation where individualized prophylactic activities, including smoking cessation and pharmacological therapy, were recommended. If not already prescribed, low dose aspirin (75 mg/day) and simvastatin (40 mg/day) were prescribed. Those with an aneurysm larger than 50 mm in diameter were referred to a vascular surgeon to assess the need for elective repair. Men with suspected hypertension were referred to their general practitioner.

The screening and usual care groups were followed using national registries for hospital admissions, surgeries, and overall and cause-specific death. After five years, 149 more lives were saved in the screening group (there were 2,566 deaths in the screening group versus 2,715 in the control group). This corresponds to one life saved for every 169 men screened, and a statistically significant 7 percent relative risk reduction compared to no screening.

“A result of this magnitude has never been seen before in general population screening programs,” Lindholt explained. “We believe that it is primarily explained by the 2.5 times higher incidence of elective aneurysm repairs and the doubled initiation rates of antithrombotic and lipid-lowering therapy in the group invited to screening.”

The cost of screening (using 2014 prices) was estimated at an additional €148 per citizen in comparison with usual care from a healthcare sector perspective. The resulting costs of a life year and a quality adjusted life year gain from screening were estimated at €6,872 and €7,716, respectively, and the corresponding probabilities for screening being cost effective at 97 and 96 percent, respectively.

“A cost per life year gained of around €7,000 is quite low by European standards,” said co-investigator Rikke Søgaard, professor of health economics at Aarhus University, Denmark. “Vascular screening is simple and cheap and the benefit in terms of lives saved is substantial. It is more cost effective than many existing programs such as screening for breast or colon cancer and has the potential to be a game changer in public health prevention.”

The trial was sponsored by the European Union, the Central Denmark Region, The Danish Independent Research Council, and the Regional Hospital of Viborg.

Watch the related VIDEO: Atherosclerosis Assessment by Ultrasound in Everyday Practice — ASE session presented by Sharon Mulvagh M.D., FASE, FACC, FRCPC, professor of medicine, Dalhousie University, Halifax, Nova Scotia, Canada, and Mayo Clinic. 

VIDEO: Vascular Ultrasound in Subclinical Disease — ASE session presented by Valentin Fuster, M.D., Ph.D., chief of the Division of Cardiology and director of Mount Sinai Heart. 

For more information: http://congress365.escardio.org

 

Links to all the late-breaking ESC 2017 trial presentations.

 

 

Related Content

The Current Direction of Healthcare Reform Explained by CMS Administrator Seema Verma
News | Cardiovascular Business | June 11, 2019
Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma addressed the American Medical Association (...
DAIC Earns Azbee National Bronze Award for Social Media Presence
News | Cardiovascular Business | May 10, 2019
May 10, 2019 — Diagnostic and Interventional Cardiology (DAIC) earned a Bronze Award at the 2019 Na
Cath lab staff working as a team to prepare for a procedure at Presbyterian Medical Center Cardiac Cath Lab, Charlotte N.C. Pictured are Barry Horsey RCIS, Emily Luna RN, RCIS, Adam Martin RCIS, Caleadia Jessup RN.

Cath lab staff working as a team to prepare for a procedure at Presbyterian Medical Center Cardiac Cath Lab, Charlotte N.C. Pictured are Barry Horsey RCIS, Emily Luna, RN, RCIS, Adam Martin, RCIS, Caleadia Jessup, RN.

Feature | Cardiovascular Business | May 03, 2019 | Ruben Filimonczuk, RCES, AS-PMD
One of the most promising areas for innovation in healthcare is to be found in the workforce – both in hiring and ret
Fail-safe Program for New Medical Technology Focuses on Patient Safety
News | Cardiovascular Business | April 29, 2019
New medical technology offers the promise of improving patient care, as well as the potential for harm if caregivers...
Medicare Trustees Report Hospital Insurance Trust Fund Will Deplete in Seven Years
News | Cardiovascular Business | April 22, 2019
The Medicare Hospital Insurance (HI) Trust Fund, which funds Medicare Part A, will only be able to pay full benefits...
Videos | Cardiovascular Business | April 16, 2019
A discussion with Ruth Fisher, MBA, vice president of the...
Foreign-trained doctors now make up one-third of cardiologists in the United States and help make up for the U.S. overall shortage of physicians. Pictured here is co-author of this article Mandeep R. Mehra, MBBS, MSc, FRCP, who is an example of the contribution international physicians have made in the U.S. He is medical director of the Brigham and Women’s Hospital Heart and Vascular Center.

Foreign-trained doctors now make up one-third of cardiologists in the United States and help make up for the overall shortage of physicians. Pictured here is co-author of this article Mandeep R. Mehra, MBBS, MSc, FRCP, who is an example of the contribution international physicians have made in the U.S. He is medical director of the Brigham and Women’s Hospital Heart and Vascular Center, The William Harvey Distinguished Chair in Advanced Cardiovascular Medicine, and a professor of medicine at Harvard Medical School. He is past-president of both the Heart Failure Society of America and the International Society of Heart and Lung Transplantation. 

Feature | Cardiovascular Business | April 15, 2019 | William W. Pinsky, M.D., FAAP, FACC, and Mandeep R. Mehra, MBBS, MSc , FRCP
As we strive to process today’s successive news cycles involving negative reports about immigration, it is easy for m
ACC Combines NCDR, Accreditation Into New Quality Summit
News | Cardiovascular Business | March 15, 2019
The American College of Cardiology’s first annual ACC Quality Summit, held March 13-15 in New Orleans, merges the NCDR...
Diagnostic and Interventional Cardiology Named 2019 Azbee Awards Finalist for Social Media
News | Cardiovascular Business | March 08, 2019 | Jeff Zagoudis, Associate Editor
Diagnostic and Interventional Cardiology (DAIC) was named a finalist in the Social Media Presence category for the 2019...
Overlay Init